ReviewClinical drug investigation2016

The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease.

Nicolas Roberto RoblesPubMed ↗Publisher ↗

No numbers read from the abstract.